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Abstract
Background: This study aimed to determine whether vitamin D deficiency is more common in children with familial
Mediterranean fever (FMF) than in healthy individuals.
Methods: The study group consisted of 100 patients diagnosed with FMF and 50 healthy children. Serum baseline
25-hydroxyvitamin D levels and other related parameters were evaluated.
Results: The mean (standard deviation [SD]) vitamin D levels in patients with FMF and healthy controls were 24.78
(8.35) and 28.70 (11.70) ng/mL, respectively. Patients with FMF had significantly decreased vitamin D levels compared
with those in healthy controls (P = 0.039). Vitamin D levels were similar in patients with FMF with different MEFV
mutations (P = 0.633). Age was significantly correlated with vitamin D levels (r = −0.235, P = 0.019). In addition, a
negative correlation between parathyroid hormone and vitamin D levels was detected (rs = −0.382, P < 0.0001).
Conclusion: This study demonstrated that vitamin D levels are lower in children with FMF than in healthy controls.
We speculate that vitamin D levels should be carefully examined, and nutritional supplementation may be required in
patients with FMF. Further studies with larger patient populations are needed to confirm the frequency of vitamin D
deficiency in patients with FMF.
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Background
Familial Mediterranean fever (FMF) is an autosomal reces-
sive disease that is prevalent among eastern Mediterranean
populations, mainly non-Ashkenazi Jews, Armenians,
Turks, and Arabs [1]. Patients experience recurrent,
self-limiting inflammatory febrile attacks, as well as ab-
dominal, chest, and joint pain. The factors that trigger
or terminate these periodic attacks are unknown. Some
patients with FMF have chronic immune activation,
reflected by subtle clinical signs of inflammation, such
as chronic normocytic normochromic anemia, spleno-
megaly, decreased bone mineral density, persistent eleva-
tion of fibrinogen levels and erythrocyte sedimentation
rates (ESRs), and growth retardation [2].
In recent years, the discovery of vitamin D receptors
on immune cells and the fact that several of these cells
produce vitamin D suggest that vitamin D may have
immunoregulatory properties. Vitamin D, in addition to
phosphorus and calcium, has pleiotropic immunomodu-
lating effects [3]. Vitamin D status has been linked to
the occurrence and severity of autoimmune and inflam-
matory diseases [4].
FMF is an inflammatory disease that is more common
in populations surrounding Mediterranean sea. The disease
is prevalent in 0.1 % of the Turkish population, and one in
five individuals is a carrier of mutations [1]. Our study is
valuable, as it includes a large number of pediatric patients
with FMF. As low-grade inflammation occurs in FMF, we
aimed to determine whether vitamin D deficiency is more
prevalent in children with FMF than in healthy individuals.
Methods
Subjects
The study group included 100 patients with a diagnosis
of FMF who received medical care at Istanbul Cerrahpasa
Medical Faculty of Rheumatology outpatient clinics.
Patients with other known chronic diseases were excluded.
None of the patients was in the attack period of FMF. All
patients were receiving treatment with colchicine, whereas
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no patient in the control group was receiving any medica-
tion that could affect vitamin D levels. Blood samples were
drawn in the summer (June-July 2013). The control group
comprised 50 age-and sex-matched healthy children. Blood
samples were taken from the healthy controls for another
medical reason with parent approval. The diagnosis of
FMF was established according to criteria defined by
Yalcınkaya et al. [5]. The study was approved by the local
ethics committee of the Istanbul Education and Re-
search Hospital and was conducted in accordance with
the Declaration of Helsinki.
Measurements
Blood samples were obtained from patients with FMF
and controls. Serum samples for vitamin D measure-
ments were obtained by centrifugation within 2 h after
blood samples were drawn and frozen at −80 °C prior to
analysis. The frozen samples were transferred properly
(on dry ice in the dark) to Acıbadem Labmed (Istanbul,
Turkey). The experiments were performed using an Agi-
lent 6460 triple quadrupole liquid chromatography (LC)/
mass spectrometry system equipped with an electrospray
ionization ion source interface in the positive ion mode
(Agilent Technologies, Santa Clara, CA, USA). The lower
detection limit was 3.0 ng/mL. At a mean of 16.13 ng/mL,
the inter-assay coefficient value (CV) was 3.37 %, and at a
mean of 50.96 ng/mL, the inter-assay CV was 1.52 %
(Chromsystems Mass Check, Gräfelfing, Germany).
In the Istanbul Education and Research Hospital Central
Biochemistry Laboratory, routine biochemical analyses of
serum samples were performed using an Advia 2400
Chemistry System. Parathyroid hormone (PTH) levels
were measured using a Centaur XP hormone analyzer,
fibrinogen content was determined using a Sysmex CA-
1500 automated coagulometer, and C-reactive protein
(CRP) levels were measured using a BNII nephelometer
(Siemens Healthcare Diagnostics Inc).
Gene mutations were detected previously and included
in the retrospective file records of the patients with
FMF. Plasma vitamin D levels were categorized as fol-
lows: sufficient, 25–80 ng/mL; mild-moderate deficiency,
10–24 ng/mL; and severe deficiency, 0–10 ng/mL. These
reference intervals for serum 25. OH-D vit levels were
reported by Acıbadem Labmed (Istanbul, Turkey) com-
patible with the literature [6]. The reference intervals for
vitamin D metabolites are method-dependent, and the
lower limit of 25.OH-D vit levels considered sufficient
for health is controversial, as vitamin D levels vary ac-
cording to season, localization, skin type, nutritional sta-
tus, sun exposure, and lifestyle [7].
Statistical analyses
Statistical analysis was performed using the Number
Cruncher Statistical System 2004 (NCSS Systems, Kaysville,
UT, USA) and MedCalc (MedCalc Software, Broekstraat,
Mariakerke, Belgium). Kolmogorov-Smirnov goodness-of-
fit tests were used to determine whether the variables
exhibited a Gaussian distribution. Normally distributed nu-
merical variables were expressed as the mean (standard de-
viation [SD]) if normally distributed, and values that lacked
a normal distribution were expressed as the median (inter-
quartile range [IQR]). Pearson’s chi-squared tests were used
to compare categorical variables. Statistical comparisons of
the two groups were performed using Student’s t-tests for
data with a Gaussian distribution or Mann–Whitney U-
tests for data with a non-Gaussian distribution. Pearson’s
correlation coefficient (r), Spearman’s rank correlation coef-
ficient (rs), or a biserial correlation coefficient was used to
evaluate the degree of association between two vari-
ables. Two-way analysis of variance was performed to
identify a significant interaction effect between the in-
dependent variables. All statistical tests were two-sided,
and P < 0.05 denoted statistical significance.
Results
The demographic characteristics and main laboratory pa-
rameters of the patients and controls are summarized in
Table 1. Among the patients with FMF, the median age at
diagnosis of FMF was 6 years (IQR, 4–10 years), and the
Table 1 Demographic characteristics and main laboratory
parameters of patients with and without familial Mediterranean
fever
Familial Mediterranean
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median duration since onset was 3 years (IQR, 2–5 years).
In total, 48 (48 %) patients had articular findings, and no
patients had renal involvement. The presenting symptoms
were abdominal pain and fever for 39 (39 %) patients, ab-
dominal pain/fever/arthritis/arthralgia for 28 (28 %) pa-
tients, isolated arthritis/arthralgia for 8 (8 %) patients,
abdominal pain/fever/skin lesions for 5 (5 %) patients,
fever/arthritis/arthralgia for 5 (5 %) patients, and other
symptoms (chest pain, myalgia, and skin lesions) for 13
(13 %) patients. Additionally, 37 (37 %) patients had a
family history of FMF.
Serum levels of calcium, phosphorus, PTH, and vita-
min D were compared between the groups (Table 2).
The mean (SD) vitamin D levels in patients with FMF
and healthy controls were 24.78 (8.35) and 28.70 (11.70)
ng/mL, respectively. Plasma vitamin D levels were sig-
nificantly lower in patients with FMF than in the con-
trols (P = 0.039)
Vitamin D levels were deficient in 38.0 % (19/50) and
sufficient levels in 62.0 % (31/50) of control group. In
addition 57.0 % (57/100) were deficient and 43.0 %
(43/100) were in sufficient levels of FMF patients. (P =
0.024) (Table 3). Pearson’s chi-square test was used to
compare observed levels with expected frequencies.
The deficiency of the patients according to frequency of
mild,moderate and severe deficiencies were %2 (2/100),
%31 (31/100), %26 (26/100) and for the control group
%6 (3/50), %14 (7/50),%16 (8/50) respectively.
An increase in age was significantly correlated with a
decrease in vitamin D levels (r = −0.235, P = 0.019). Add-
itionally, a negative correlation was detected between
PTH and vitamin D levels (rs = −0.382, P < 0.0001). No
significant correlation was noted between vitamin D
levels and the ESR or CRP levels.
Plasma vitamin D levels were not significantly different
between patients with (n = 48) and without articular
symptoms (n = 52) (23.72 [7.93] ng/mL versus 25.20
[8.99] ng/mL, P = 0.328).
Meanwhile, plasma vitamin D levels were similar
among patients with FMF with different MEFV muta-
tions (P > 0.05) (Table 4). The most prevalent muta-
tions detected as M694V HT (N = 18,%18) and M694
HM (N = 16,%16) respectively.
Discussion
Our study established that vitamin D deficiency is present
in a large number of Turkish children diagnosed with
FMF.
The influence of vitamin D deficiency on inflammation
is being explored, but studies have not demonstrated a
causative effect. FMF is autoinflammatory disease in
which MEFV mutations change pyrin protein and thus
inflammasome activity in cells of innate immune system
[2]. The vitamin D effect on innate immun cells also in-
vestigated in other autoinflamatuar diseases like Behcet
Disease(B.D.).Do JE et al. underlined the immunomodu-
latrory effect of vitamin D through down regulation of
Toll-like receptor(TLR) expression in human monocytes.
They also suggested that vitamin D may have an immu-
nomodulatory effect on innate immunity-mediated in-
flammation in BD [8].
Some researchers hypothesized that low vitamin D is
the consequence of a chronic inflammatory process
caused by persistent infection [9]. The mechanism by
which vitamin D reduces inflammation remains poorly
understood. T helper cells playing a crucial role in FMF
pathogenesis produce interferon (IFN)-gamma and tumor
necrosis factor (TNF)-beta [10, 11]. Aypar et al. identified
elevated IFN-gamma levels produced by Th-1 cells during
FMF attacks compared to those in healthy controls and
suggested that Th-1 polarization may trigger inflammation
in patients with FMF [12]. Vitamin D, which possesses
immunomodulatory effects, inhibits the production of
interleukin (IL)-6 and IFN-gamma by reducing the dif-
ferentiation and maturation of myeloid, Th-1, and Th-
17 cells [13, 14]. Koklu et al. also reported elevated IFN
gamma levels in patients with FMF during both attack
and attack-free periods [15]. Additionally, some researchers
Table 2 Serum calcium, phosphorus, PTH, and plasma vitamin D levels in patients with and without familial Mediterranean fever





Calcium (mg/dl) (mean [SD]) 9.6 (0.5) 9.8 (0.4) <0.01
Phosphorus (mg/dl) (median [IQR]) 4.9 (4.5–5.2) 4.8 (4.4–5.1) 0.318
PTH (pg/mL) (median [IQR]) 49.9 (28.7–64.8) 34.2 (24.2–53.2) 0.024
25-OH vitamin D (ng/mL) (mean [SD]) 24.78 (8.35) 28.70 (11.70) 0.039
PTH parathyroid hormone, SD standard deviation, IQR interquartile range








< 25 ng/mL (n, %)
57 (57.0 %) 19 (38.0 %) 0.024
Vitamin D =
25–80 ng/mL (n, %)
43 (43.0 %) 31 (62.0 %)
Onur et al. Pediatric Rheumatology  (2016) 14:28 Page 3 of 5
connected low vitamin D levels to malabsorption of the
vitamin as a result of colchicine treatment. Padeh et al.
reported that 14 % of patients developed diarrhea during
colchicine treatment [16].
We detected significantly lower serum 25-hydroxy
vitamin D levels among patients with FMF than in
matched controls (P < 0.01), and female patients with
FMF were most strongly affected. Female (N = 54) and
male (N = 46) patient’s mean vitamin D levels were
23.09 (18.79–26.53) and 26.01 (20.79–32.35) respectively
(P = 0.014). Most previous studies were conducted in adults
with FMF. Recently, Erten et al. [17] and Kisacik et al. [18]
detected significantly lower serum 25-hydroxyvitamin D
levels among patients with FMF than in matched controls
(P < 0.001). Female patients with FMF were also most
greatly affected in the study by Erten et al. [17]. They asso-
ciated this result with styles of dress, low activity levels, and
inadequate exposure to sunlight.
Chronic inflammation is associated with a decrease in
bone mineral density in patients with various inflamma-
tory diseases, and attack-free patients with FMF have
considerably lower T-scores at the femur neck and lumbar
spine than healthy individuals, reflecting their increased
risk of developing early-onset osteoporosis [19–21]. In-
flammatory activity in patients with FMF plays a major
role in the pathophysiology of bone loss. This may be me-
diated by substances regulating both the inflammatory
process and bone turnover [22]. Alterations in vitamin D
metabolism can cause increases in bone resorption [23].
Osteoporosis in patients with FMF can also be related to
decreased vitamin D levels [17]. Similarly, we detected a
negative correlation between vitamin D and PTH levels,
and a negative correlation between alkaline phosphatase
and vitamin D levels has been reported, emphasizing the ef-
fects of vitamin D deficiency in patients with FMF. We
propose that convenient nutritional supplementation would
prevent the likely development of osteoporosis in patients
with FMF. In a recent study, Zhang et al. supported the
idea that serum vitamin D levels should be maintained at
more than 30 ng/mL in the physiologic range to achieve
sufficient anti-inflammatory effects [24]. Erten et al. con-
cluded that vitamin D levels were significantly lower in
adult patients who presented with joint symptoms as the
first presentation than in those who presented with abdom-
inal attacks. In our study, plasma vitamin D levels were not
significantly different between patients with and without ar-
ticular symptoms [17]. We speculate that this finding may
be associated with the ages of patients in our study.
Some authors also detected increased inflammation in
carriers of MEFV mutations [25]. We investigated this
association, but no significant correlation was detected
(P = 0.633). Erten et al. [17] demonstrated that increased
levels of inflammatory markers (ESR and fibrinogen) in
patients with FMF were correlated with lower vitamin D
levels. We also investigated this association but found no
significant correlations among these markers (P > 0.05).
This indicates that colchicine treatment suppressed in-
flammation. Increased inflammation exists in the attack
period, and thus, we are planning to investigate vitamin D
levels in this period in our future studies.
In a recent study, Anık et al. [26] also detected de-
creased vitamin D levels in children and indicated that
the cumulative colchicine dose appears to negatively
affect vitamin D levels. It was concluded that colchicine
inhibited the functions of intracellular microtubules,
which are essential components of the normal genomic
response to vitamin D. Defects in the microtubular net-
work attributable to colchicine use may reduce vitamin
D levels because of increased production of 1,25(OH)
vitamin D and 24,25(OH) vitamin D [26, 27]. Future
studies should investigate the potential association between
the colchicine dose and vitamin D status.
Our study had some limitations. We could not consider
variables that can influence vitamin D levels such as diet-
ary intake, physical activity status, sunlight exposure, in-
creased skin pigmentation, and genetic polymorphisms of
vitamin D receptors. In addition, the associations among
the cumulative colchicine dose, acute attack periods, and
severity scores have not been examined thoroughly. Our
planned studies will investigate these associations.
To date, few studies have investigated vitamin D defi-
ciency in patients with FMF. As our study is the first to
include a large number of patients with FMF and con-
trols, it has significant validity.
Conclusion
In conclusion, scientific research has not clarified whether
vitamin D deficiency is a consequence or cause of inflam-
matory disease. This study demonstrated that vitamin D
levels are lower in children with FMF than in healthy con-
trols. We speculate that vitamin D levels should be care-
fully examined, and nutritional supplementation may be
required in patients with FMF. Further studies with larger
patient populations are needed to investigate vitamin D
deficiency in patients with FMF.
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